The National Institute of Allergy and Infectious Diseases (NIAID) is providing this grant to continue operations support for Biosafety Level 4 (BSL4) facilities at the National Biocontainment Laboratories at UTMB and Boston University. The grant entails facility maintenance, biosecurity, regulatory compliance, and research support services to facilitate pre-clinical and laboratory research on hazardous biological agents for biodefense and emerging infectious diseases. During national emergencies in biodefense or emerging infectious diseases, the NBLs may also support response efforts in the US under the direction of NIAID. Application deadline: July 17, 2020.
Opportunity ID: 326081
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-AI-20-026 |
| Funding Opportunity Title: | Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 2 |
| Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Apr 06, 2020 |
| Last Updated Date: | Apr 06, 2020 |
| Original Closing Date for Applications: | Jul 17, 2020 |
| Current Closing Date for Applications: | Jul 17, 2020 |
| Archive Date: | Aug 22, 2020 |
| Estimated Total Program Funding: | $23,000,000 |
| Award Ceiling: | $11,500,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Public and State controlled institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. See FOA for full eligibility details. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The goal of this Funding Opportunity Announcement (FOA) is to continue to provide operations support for Biosafety Level 4 (BSL4) facilities to the National Biocontainment Laboratories at the University of Texas Medical Branch (UTMB) in Galveston, Texas and Boston University in Boston, Massachusetts. Operations support is provided in the following areas: facility maintenance and operations; biosecurity; environmental health and safety regulations and requirements; regulatory compliance; and specialized research support services. The NBLs will serve as a national resource for efforts in conducting pre-clinical and laboratory (in vitro and in vivo) research and testing on hazardous biological agents in support of NIAIDs biodefense and emerging infectious diseases research efforts. Additionally, in times of a national biodefense or emerging infectious disease (EID) emergency, the NBLs may be expected to rapidly realign their activities to assist response efforts within the US under the direction of NIAID. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-20-026.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00260803 | Jun 17, 2020 | Jul 17, 2020 | View |
Package 1
Mandatory forms
326081 RR_SF424_2_0-2.0.pdf
326081 PHS398_CoverPageSupplement_5_0-5.0.pdf
326081 RR_OtherProjectInfo_1_4-1.4.pdf
326081 PerformanceSite_2_0-2.0.pdf
326081 RR_KeyPersonExpanded_2_0-2.0.pdf
326081 PHS398_ResearchPlan_4_0-4.0.pdf
326081 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
326081 PHS_Additional_IndirectCosts-1.0.pdf
326081 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
